1 / 24

Global Clinical Trial Management System Market to 2019

Clinical trial is a medical research study performed on humans to check the safety and efficacy of drugs, devices and therapeutic products before they are finally launched in the market. Proper management of clinical trials has become a priority for hospitals, pharmaceutical companies and clinical research organizations (CRO).

addiethomes
Download Presentation

Global Clinical Trial Management System Market to 2019

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. BeautyDevicesMarket-GlobalStudyonClinicalTrialManagement System-AsiatoWitnessHighestGrowthby2019 PersistenceMarketResearch GlobalClinicalTrialManagementSystem MarketWillReach$1,848.5millionin2019: PersistenceMarketResearch 1 PersistenceMarketResearch

  2. BeautyDevicesMarket-GlobalStudyonClinicalTrialManagement System-AsiatoWitnessHighestGrowthby2019 PersistenceMarketResearchReleasedNewMarketReport“GlobalMarketStudyonClinicalTrial ManagementSystem:AsiatoWitnessHighestGrowthby2019”theglobalclinicaltrial managementsystemmarketwasvaluedatUSD844.0millionin2013andisexpectedtogrow ataCAGRof14%from2014to2019,toreachanestimatedvalueofUSD1,848.5millionin 2019. BrowsethefullGlobalMarketStudyonClinicalTrialManagementSystem:AsiatoWitness HighestGrowthby2019reportathttp://www.persistencemarketresearch.com/market-research/clinical-trial-management-system-market.asp Clinicaltrialisamedicalresearchstudyperformedonhumanstocheckthesafetyand efficacyofdrugs,devicesandtherapeuticproductsbeforetheyarefinallylaunchedinthe market.Globally,theCTMSmarketiswitnessingsignificantgrowthduetoincreasingR&D investmentinpharmaceutical,lifescienceandclinicalresearchindustries.Itempowers organizationsandresearchcenterstoenhanceproductivityandeffectivenessofclinical trialsbyadvancingandmanagingclinicaltrials.IntegrationofCTMSwithhospital informationsystem(HIS)providesmoreaccurateandtimesavingdocumentationisalso drivinggrowthfortheCTMSmarket.Additionally,increasingprevalenceofdiseasesis supportingclinicaltrialsindifferentregions,andincreasedclinicalresearchoutsourcingis playingamajorroleinthegrowthoftheCTMSmarket.Increasingregulatoryrequirementsin manycountrieshasresultedinincreasedcomplexityforclinicaltrialprotocols.Presenceof variousenduserssuchaspharmaceuticals,clinicalresearchorganizations(CRO)and healthcareprovidershasincreasedtheacceptanceofCTMS.TheglobalCTMSmarketwas estimatedtobeUSD844millionin2013.ItislikelytogrowataCAGRof14%during2013to 2019toreachUSD1,848.5millionin2019. NorthAmericaisatraditionalclinicaltrialregion.Duetoregulatoryandlegalconsiderations andtheclinicaltrialmarkethasshiftedfromNorthAmericatodevelopingcountriessuchasIndiaandChina.ClinicaltrialsintheU.S.havebeenfundedandsponsoredbyNationalInstituteofHealth(NIH),othergovernmentagencies,academicgroups,voluntaryhealthorganizationsandindustry. InEurope,countriesinCentralandEasternEuropeprovideabundantchancetolifescience companiesforclinicaldevelopment.Duetogovernmentalsupportandfundingforbiomedicalsciences,Germanyhasbecomeapreferredlocationforclinicaltrials. However,Asiaisthefastestgrowingregionintheclinicaltrialmanagementsystemmarket.. ImprovedindustryregulatorylawsandpatentexpirationlawsinvariouscountriesincludingJapan,ChinaandIndia,haveledtotheexpansionoftheclinicaltrialsmarketinAsia.AsiahaslowercostofconductingclinicaltrialscomparedtoEuropeortheU.S. 2 PersistenceMarketResearch

  3. BeautyDevicesMarket-GlobalStudyonClinicalTrialManagement System-AsiatoWitnessHighestGrowthby2019 SomeofthemajorplayersintheCTMSmarketareOracleCorporation,Bio-Optronics, MedNetSolutions,PAREXELInternationalCorporation,MedidataSolutionsandBioClinica Theclinicaltrialmanagementsystemmarketissegmentedasfollows: ClinicalTrialManagementSystemMarket,ByDeliveryMode Cloudbasedclinicaltrialmanagementsystem Webbasedclinicaltrialmanagementsystem On-premiseclinicaltrialmanagementsystem ClinicalTrialManagementSystemMarket,ByType Enterprisebasedclinicaltrialmanagementsystem Sitebasedclinicaltrialmanagementsystem ClinicalTrialManagementSystemMarket,ByEnduser Pharmaceuticals ClinicalResearchOrganizations Healthcareproviders ClinicalTrialManagementSystemMarket,ByComponents Software Hardware Services ClinicalTrialManagementSystemMarket,byGeography NorthAmerica U.S. Europe Germany France U.K. 3 PersistenceMarketResearch

  4. BeautyDevicesMarket-GlobalStudyonClinicalTrialManagement System-AsiatoWitnessHighestGrowthby2019 Russia Poland Asia China SouthKorea Taiwan India RestoftheWorld(RoW) MarketHistory: Clinicaltrialmanagementsystem(CTMS)isasoftwaresolutionforpropermanagement,storageand analysisofdrugsassociatedclinicaldata.Globally,themicrofluidicdevicemarketiswitnessing significantgrowthduetoincreasingR&Dinvestmentinpharmaceuticals,lifescienceandrisingpointof caretestingdemand.Newtrendsinhealthcare,suchashealthcareathome,supportspointofcare testing(POCT)as themostefficientandeffectivedeliveryofhealthcare. Additionally,themicrofluidictechniquehasevolvedintoanewclassificationofresearchareas,targeting integrationoflaboratoryprotocolsintominiaturizeddevicescalledlabonchip.Miniaturizationreducesthe costforscreeningcompoundsinpharmaceuticalcompaniesforcellbiologyproblems.Microfluidic devicesoffervariousadvantagesforgenomicsincludingimprovedtestspeed,reducedreagent consumptionandefficacy.Presenceofvariousenduserssuchaspharmaceuticals,clinicalresearch organizations(CRO)andhealthcareprovidershasincreasedtheacceptanceofCTMS.TheCTMS marketwasestimatedtobeUSD844millionin2013.ItislikelytogrowataCAGRof14%during2013to 2019toreachUSD1,848.5millionin2019. NorthAmericahasthelargestmarketshareintheglobalCTMSmarket.WebbasedCTMSisthelargest modeofdeliveryandpharmaceuticalindustryisthelargestenduserofCTMS.Intermsofgrowth,Asiais thefastestgrowingregion,cloudbasedCTMSisthefastestgrowingmodeofdeliveryandCRO’sarethe fastestgrowingendusersofCTMS. 4 PersistenceMarketResearch

  5. BeautyDevicesMarket-GlobalStudyonClinicalTrialManagement System-AsiatoWitnessHighestGrowthby2019 NorthAmericanmarketforCTMSwasestimatedatUSD514.4millionin2013andisexpectedtoreach USD1,107.5millionin2019,growingataCAGRof13.6%from2013to2019. WebbasedCTMSwasestimatedatUSD603.4millionin2013andisexpectedtoreachUSD1,392.1 millionin2019,growingataCAGRof15%from2013to2019. SoftwaresegmentwasestimatedatUSD585millionin2013andisexpectedtoreachUSD1,274.2 millionin2019,growingataCAGRof13.9%from2013to2019. TableofContent Chapter1Preface12 1.1ReportDescription12 1.2ResearchMethodology13 5 PersistenceMarketResearch

  6. BeautyDevicesMarket-GlobalStudyonClinical System-AsiatoWitnessHighestGrowthby2019 Trial Management 1.3Assumptions13 Chapter2MarketSynopsis14 Chapter3PorterFiveForcesAnalysis16 3.1Bargainingpowerofsuppliers16 3.2Bargainingpowerofbuyers16 3.3Threatofnewentrants17 3.4Threatofsubstitutes17 3.5Intensityofrivalry17 Chapter4IndustryOverview18 4.1MarketDefinition18 4.2MarketDrivers20 4.2.1Increasingresearch industry20 and development (R&D)investmentinthepharmaceutical 4.2.2Increasingprevalenceofdiseaseissupportingimportanceofclinicaltrialsindifferent regionsoftheworld22 6 PersistenceMarketResearch

  7. BeautyDevicesMarket-GlobalStudyonClinicalTrialManagement System-AsiatoWitnessHighestGrowthby2019 4.2.3AssimilationofclinicaltrialmanagementsystemswithHospitalInformationSystem (HIS)22 4.2.4Increasedclinicalresearchoutsourcingandimplementationofclinicaltrialsbycontract researchorganizations23 4.3ImpactAnalysisofMarketDrivers24 4.4MarketRestraints24 4.4.1Longerapprovaltimeforclinicaltrials24 4.4.2Strictregulationstoenrolpatientsforclinicaltrials25 4.5ImpactAnalysisofMarketRestraints26 4.6MarketTrends26 4.6.1Risingnumberofcollaborationsandpartnerships26 4.6.2Increasingnumberofmergersandacquisitions27 Chapter5GlobalMarketSizeandForecast29 Chapter6MarketSizeandForecastbyModeofDelivery31 6.1Cloudbasedclinicaltrialmanagementsystem31 6.2Webbasedclinicaltrialmanagementsystem32 7 PersistenceMarketResearch

  8. BeautyDevicesMarket-GlobalStudyonClinical System-AsiatoWitnessHighestGrowthby2019 Trial Management 6.3On-premiseclinicaltrialmanagementsystem32 Chapter7MarketSizeandForecastbyEndUser34 7.1Pharmaceuticals34 7.2ClinicalResearchOrganizations(CROs)34 7.3HealthcareProviders35 Chapter8MarketSizeandForecastbyType37 8.1Enterprisebasedclinicaltrialmanagementsystem37 8.2Sitebasedclinicaltrialmanagementsystem37 Chapter9MarketSizeandForecastbyComponents39 9.1Software39 9.2Hardware40 9.3Services40 Chapter10MarketSizeandForecastbyGeography42 10.1NorthAmerica42 8 PersistenceMarketResearch

  9. BeautyDevicesMarket-GlobalStudyonClinical System-AsiatoWitnessHighestGrowthby2019 Trial Management 10.1.1TheU.S.49 10.2Europe53 10.2.1Germany61 10.2.2France65 10.2.3Poland68 10.3Asia71 10.3.1SouthKorea79 10.3.2China82 10.4RestoftheWorld86 Chapter11CompetitiveScenario87 11.1CompetitiveBenchmarking87 Chapter12CompanyProfiles89 12.1OracleCorporation89 12.1.1CompanyOverview89 12.1.2ProductsandServices90 9 PersistenceMarketResearch

  10. BeautyDevicesMarket-GlobalStudyonClinical System-AsiatoWitnessHighestGrowthby2019 Trial Management 12.1.3FinancialPerformance90 12.1.4RecentDevelopments91 12.2MergeHealthcareIncorporated92 12.2.1CompanyOverview92 12.2.2ProductsandServices93 12.2.3FinancialPerformance93 12.2.4RecentDevelopments94 12.3MedidataSolutionsInc.95 12.3.1CompanyOverview95 12.3.2ProductsandServices95 12.3.3FinancialPerformance96 12.3.4RecentDevelopments96 12.4PAREXELInternationalCorporation98 12.4.1CompanyOverview98 12.4.2ProductsandServices98 12.4.3FinancialPerformance98 10 PersistenceMarketResearch

  11. BeautyDevicesMarket-GlobalStudyonClinical System-AsiatoWitnessHighestGrowthby2019 Trial Management 12.4.4RecentDevelopments99 12.5BioClinica100 12.5.1CompanyOverview100 12.5.2ProductsandServices100 12.5.3FinancialPerformance100 12.5.4RecentDevelopments101 12.6MedNetSolutions,Inc.103 12.6.1CompanyOverview103 12.6.2ProductsandServices103 12.6.3FinancialPerformance103 12.6.4RecentDevelopments103 12.7Bio-Optronics,Inc.105 12.7.1CompanyOverview105 12.7.2ProductsandServices105 12.7.3FinancialPerformance105 12.7.4RecentDevelopments105 11 PersistenceMarketResearch

  12. BeautyDevicesMarket-GlobalStudyonClinical System-AsiatoWitnessHighestGrowthby2019 Trial Management 12.8DSG,Inc.107 12.8.1CompanyOverview107 12.8.2ProductsandServices107 12.8.3FinancialPerformance107 12.8.4RecentDevelopments107 12.9eClinForce,Inc.108 12.9.1CompanyOverview108 12.9.2ProductsandServices108 12.9.3FinancialPerformance108 12.9.4RecentDevelopments108 12.10ForteResearchSystems,Inc.109 12.10.1CompanyOverview109 12.10.2ProductsandServices109 12.10.3FinancialPerformance109 12.10.4RecentDevelopments109 12 PersistenceMarketResearch

  13. BeautyDevicesMarket-GlobalStudyonClinicalTrialManagement System-AsiatoWitnessHighestGrowthby2019 ListofTables TABLE1MarketSnapshot:CTMSmarket(2013&2019)14 TABLE2R&Dinvestmentinpharmaceuticalindustry,bycountry(USDmillion)in2010and 201121 TABLE3Globallyrisingprevalenceofdiabetics,bynumberofcases(million,2010and2030) 22 TABLE4DriversforCTMSmarket:Impactanalysis24 TABLE5Estimatedaveragetimelinesforclinicaltrialapprovalinvariouscountries25 TABLE6RestraintsforCTMSmarket:Impactanalysis26 TABLE7MajorcollaborationsandpartnershipsbyCTMScompanies(2011-February2014)27 TABLE8SomeofthemajormergersandacquisitionsinCTMSmarket(2011-Februrary2014) 28 TABLE9Globalclinicaltrialmanagementsystemmarketsize,byregion2009-2012(USD million)29 TABLE10Globalclinicaltrialmanagementsystemmarketsize,byregion2013-2019(USD million)30 TABLE11Globalclinicaltrialmanagementsystemmarketsize,bymodeofdelivery2009-2012 (USDmillion)32 TABLE12Globalclinicaltrialmanagementsystemmarketsize,bymodeofdelivery2013-2019 (USDmillion)33 13 PersistenceMarketResearch

  14. BeautyDevicesMarket-GlobalStudyonClinicalTrialManagement System-AsiatoWitnessHighestGrowthby2019 TABLE13Globalclinicaltrialmanagementsystemmarketsize,byenduser2009-2012(USD million)35 TABLE14Globalclinicaltrialmanagementsystemmarketsize,byenduser2013-2019(USD million)36 TABLE15Globalclinicaltrialmanagementsystemmarketsize,bytype2009-2012(USD million)38 TABLE16Globalclinicaltrialmanagementsystemmarketsize,bytype2013-2019(USD million)38 TABLE17Globalclinicaltrialmanagementsystemmarketsize,bycomponent2009-2012(USD million)40 TABLE18Globalclinicaltrialmanagementsystemmarketsize,bycomponent2013-2019(USD million)41 TABLE19TheNorthAmericanclinicaltrialmanagementmarketsize,bysegment2009-2012 (USDmillion)43 TABLE20TheNorthAmericanclinicaltrialmanagementmarketsize,bysegment2013-2019 (USDmillion)43 TABLE21TheNorthAmericanclinicaltrialmanagementsystemmarketsize,bymodeof delivery2009-2012(USDmillion)44 TABLE22TheNorthAmericanclinicaltrialmanagementsystemmarketsize,bymodeof delivery2013-2019(USDmillion)45 14 PersistenceMarketResearch

  15. BeautyDevicesMarket-GlobalStudyonClinicalTrialManagement System-AsiatoWitnessHighestGrowthby2019 TABLE23TheNorthAmericanclinicaltrialmanagementsystemmarketsize,byenduser2009- 2012(USDmillion)46 TABLE24TheNorthAmericanclinicaltrialmanagementsystemmarketsize,byenduser2013- 2019(USDmillion)46 TABLE25TheNorthAmericanclinicaltrialmanagementsystemmarketsize,bytype2009- 2012(USDmillion)47 TABLE26TheNorthAmericanclinicaltrialmanagementsystemmarketsize,bytype2013- 2019(USDmillion)48 TABLE27TheNorthAmericanclinicaltrialmanagementsystemmarketsize,bycomponent 2009-2012(USDmillion)49 TABLE28TheNorthAmericanclinicaltrialmanagementsystemmarketsize,bycomponent 2013-2019(USDmillion)49 TABLE29TheU.S.clinicaltrialmanagementsystemmarketsize,bymodeofdelivery2009- 2012(USDmillion)50 TABLE30TheU.S.clinicaltrialmanagementsystemmarketsize,bymodeofdelivery2013- 2019(USDmillion)51 TABLE31TheU.S.clinicaltrialmanagementsystemmarketsize,byenduser2009-2012(USD million)52 TABLE32TheU.S.clinicaltrialmanagementsystemmarketsize,byenduser2013-2019(USD million)52 TABLE33TheEuropeanclinicaltrialmanagementmarketsize,bysegment2009-2012(USD million)54 15 PersistenceMarketResearch

  16. BeautyDevicesMarket-GlobalStudyonClinicalTrialManagement System-AsiatoWitnessHighestGrowthby2019 TABLE34TheEuropeanclinicaltrialmanagementmarketsize,bysegment2013-2019(USD million)55 TABLE35TheEuropeanclinicaltrialmanagementsystemmarketsize,bymodeofdelivery 2009-2012(USDmillion)56 TABLE36TheEuropeanclinicaltrialmanagementsystemmarketsize,bymodeofdelivery 2013-2019(USDmillion)57 TABLE37TheEuropeanclinicaltrialmanagementsystemmarketsize,byenduser2009-2012 (USDmillion)58 TABLE38TheEuropeanclinicaltrialmanagementsystemmarketsize,byenduser2013-2019 (USDmillion)58 TABLE39TheEuropeanclinicaltrialmanagementsystemmarketsize,bytype2009-2012 (USDmillion)59 TABLE40TheEuropeanclinicaltrialmanagementsystemmarketsize,bytype2013-2019 (USDmillion)60 TABLE41TheEuropeanclinicaltrialmanagementsystemmarketsize,bycomponent2009- 2012(USDmillion)61 TABLE42TheEuropeanclinicaltrialmanagementsystemmarketsize,bycomponent2013- 2019(USDmillion)61 TABLE43TheGermanclinicaltrialmanagementsystemmarketsize,bymodeofdelivery2009- 2012(USDmillion)62 16 PersistenceMarketResearch

  17. BeautyDevicesMarket-GlobalStudyonClinicalTrialManagement System-AsiatoWitnessHighestGrowthby2019 TABLE44TheGermanclinicaltrialmanagementsystemmarketsize,bymodeofdelivery2013- 2019(USDmillion)63 TABLE45TheGermanclinicaltrialmanagementsystemmarketsize,byenduser2009-2012 (USDmillion)64 TABLE46TheGermanclinicaltrialmanagementsystemmarketsize,byenduser2013-2019 (USDmillion)64 TABLE47TheFrenchclinicaltrialmanagementsystemmarketsize,bymodeofdelivery2009- 2012(USDmillion)65 TABLE48TheFrenchclinicaltrialmanagementsystemmarketsize,bymodeofdelivery2013- 2019(USDmillion)66 TABLE49TheFrenchclinicaltrialmanagementsystemmarketsize,byenduser2009-2012 (USDmillion)67 TABLE50TheFrenchclinicaltrialmanagementsystemmarketsize,byenduser2013-2019 (USDmillion)67 TABLE51Polandclinicaltrialmanagementsystemmarketsize,bymodeofdelivery2009-2012 (USDmillion)68 TABLE52Polandclinicaltrialmanagementsystemmarketsize,bymodeofdelivery2013-2019 (USDmillion)69 TABLE53Polandclinicaltrialmanagementsystemmarketsize,byenduser2009-2012(USD million)70 TABLE54Polandclinicaltrialmanagementsystemmarketsize,byenduser2013-2019(USD million)70 17 PersistenceMarketResearch

  18. BeautyDevicesMarket-GlobalStudyonClinical System-AsiatoWitnessHighestGrowthby2019 TrialManagement TABLE55TheAsianclinicaltrialmanagementmarketsize,by million)72 segment2009-2012(USD TABLE56TheAsianclinicaltrialmanagementmarketsize,by million)73 segment2013-2019(USD TABLE57TheAsianclinicaltrialmanagementsystemmarketsize,bymodeofdelivery2009- 2012(USDmillion)74 TABLE58TheAsianclinicaltrialmanagementsystemmarketsize,bymodeofdelivery2013- 2019(USDmillion)74 TABLE59TheAsianclinicaltrialmanagementsystemmarketsize,byenduser2009-2012 (USDmillion)75 TABLE60TheAsianclinicaltrialmanagementsystemmarketsize,byenduser2013-2019 (USDmillion)76 TABLE61TheAsianclinicaltrialmanagementsystemmarketsize,bytype2009-2012(USD million)77 TABLE62TheAsianclinicaltrialmanagementsystemmarketsize,bytype2013-2019(USD million)77 TABLE63TheAsianclinicaltrialmanagementsystemmarketsize,bycomponent2009-2012 (USDmillion)78 TABLE64TheAsianclinicaltrialmanagementsystemmarketsize,bycomponent2013-2019 (USDmillion)79 18 PersistenceMarketResearch

  19. BeautyDevicesMarket-GlobalStudyonClinicalTrialManagement System-AsiatoWitnessHighestGrowthby2019 TABLE65TheSouthKoreanclinicaltrialmanagementsystemmarketsize,bymodeofdelivery 2009-2012(USDmillion)80 TABLE66TheSouthKoreanclinicaltrialmanagementsystemmarketsize,bymodeofdelivery 2013-2019(USDmillion)81 TABLE67TheSouthKoreanclinicaltrialmanagementsystemmarketsize,byenduser2009- 2012(USDmillion)82 TABLE68TheSouthKoreanclinicaltrialmanagementsystemmarketsize,byenduser2013- 2019(USDmillion)82 TABLE69TheChineseclinicaltrialmanagementsystemmarketsize,bymodeofdelivery 2009-2012(USDmillion)83 TABLE70TheChineseclinicaltrialmanagementsystemmarketsize,bymodeofdelivery 2013-2019(USDmillion)84 TABLE71TheChineseclinicaltrialmanagementsystemmarketsize,byenduser2009-2012 (USDmillion)85 TABLE72TheChineseclinicaltrialmanagementsystemmarketsize,byenduser2013-2019 (USDmillion)85 TABLE73SomeoftheOracleCorporationcategoriesandproducts90 TABLE74SomeoftheMergeHealthcarecategoriesandproducts93 TABLE75SomeoftheMedidataSolutionsproductsandapplications95 TABLE76SomeofthePAREXELInternationalCorporationcategories,productsandservices 98 19 PersistenceMarketResearch

  20. BeautyDevicesMarket-GlobalStudyonClinicalTrial System-AsiatoWitnessHighestGrowthby2019 Management TABLE77SomeoftheBioClinicacategoriesandproducts100 TABLE78SomeoftheMedNetSolutionscategoriesandproducts103 TABLE79SomeoftheBio-Optronicsproductsandapplication105 TABLE80SomeoftheDSGproductsandapplication107 TABLE81SomeoftheeClinForceproducts108 TABLE82SomeoftheForteResearchSystemsproductsandapplication109 ListofFigures FIG.1CTMSMarket:PortersFiveForceAnalysis16 FIG.2Applicationsofclinicaltrialmanagementsystem19 FIG.3ProcessofCTMS20 FIG.4Globalclinicaltrialmanagementsystemmarket,byregion2013E(%share)29 FIG.5Globalclinicaltrialmanagementsystemmarket,bymodeofdelivery2013E(%share)31 FIG.6Globalclinicaltrialmanagementsystemmarket,byenduser2013E(%share)34 FIG.7Globalclinicaltrialmanagementsystemmarket,bytype2013E(%share)37 FIG.8Globalclinicaltrialmanagementsystemmarket,bycomponents2013E(%share)39 20 PersistenceMarketResearch

  21. BeautyDevicesMarket-GlobalStudyonClinicalTrialManagement System-AsiatoWitnessHighestGrowthby2019 FIG.9TheNorthAmericanclinicaltrialmanagementsystemmarket,bycountry2013E(% share)42 FIG.10TheNorthAmericanclinicaltrialmanagementsystemmarket,bymodeofdelivery 2013E(%share)44 FIG.11TheNorthAmericanclinicaltrialmanagementsystemmarket,byenduser2013E(% share)45 FIG.12TheNorthAmericanclinicaltrialmanagementsystemmarket,bytype2013E(%share) 47 FIG.13TheNorthAmericanclinicaltrialmanagementsystemmarket,bycomponent2013E(% share)48 FIG.14TheU.S.clinicaltrialmanagementsystemmarket,bymodeofdelivery2013E(% share)50 FIG.15TheU.S.clinicaltrialmanagementsystemmarket,byenduser2013E(%share)51 FIG.16TheEuropeanclinicaltrialmanagementsystemmarket,bycountry2013E(%share)54 FIG.17TheEuropeanclinicaltrialmanagementsystemmarket,bymodeofdelivery2013E(% share)56 FIG.18TheEuropeanclinicaltrialmanagementsystemmarket,byenduser2013E(%share) 57 FIG.19TheEuropeanclinicaltrialmanagementsystemmarket,bytype2013E(%share)59 FIG.20TheEuropeanclinicaltrialmanagementsystemmarket,bycomponent2013E(% share)60 21 PersistenceMarketResearch

  22. BeautyDevicesMarket-GlobalStudyonClinicalTrialManagement System-AsiatoWitnessHighestGrowthby2019 FIG.21TheGermanclinicaltrialmanagementsystemmarket,bymodeofdelivery2013E(% share)62 FIG.22TheGermanclinicaltrialmanagementsystemmarket,byenduser2013E(%share)63 FIG.23TheFrenchclinicaltrialmanagementsystemmarket,bymodeofdelivery2013E(% share)65 FIG.24TheFrenchclinicaltrialmanagementsystemmarket,byenduser2013E(%share)66 FIG.25Polandclinicaltrialmanagementsystemmarket,bymodeofdelivery2013E(%share) 68 FIG.26Polandclinicaltrialmanagementsystemmarket,byenduser2013E(%share)69 FIG.27TheAsianclinicaltrialmanagementsystemmarket,bycountry2013E(%share)72 FIG.28TheAsianclinicaltrialmanagementsystemmarket,bymodeofdelivery2013E(% share)73 FIG.29TheAsianclinicaltrialmanagementsystemmarket,byenduser2013E(%share)75 FIG.30TheAsianclinicaltrialmanagementsystemmarket,bytype2013E(%share)76 FIG.31TheAsianclinicaltrialmanagementsystemmarket,bycomponent2013E(%share)78 FIG.32TheSouthKoreanclinicaltrialmanagementsystemmarket,bymodeofdelivery2013E (%share)80 FIG.33TheSouthKoreanclinicaltrialmanagementsystemmarket,byenduser2013E(% share)81 22 PersistenceMarketResearch

  23. BeautyDevicesMarket-GlobalStudyonClinicalTrialManagement System-AsiatoWitnessHighestGrowthby2019 FIG.34TheChineseclinicaltrialmanagementsystemmarket,bymodeofdelivery2013E(% share)83 FIG.35TheChineseclinicaltrialmanagementsystemmarket,byenduser2013E(%share)84 FIG.36CompetitivelandscapeoftheglobalCTMSmarket87 FIG.37OracleCorporationtotalrevenueandnetincome2011-2013(USDMillion)90 FIG.38MergeHealthcarenetsalesandnetincome2011-2013(USDMillion)93 FIG.39MedidataSolutionstotalrevenueandnetincome2011-2013(USDMillion)96 FIG.40PAREXELInternationalCorporationtotalservicerevenueandnetincome2011-2013 (USDMillion)99 FIG.41BioClinicatotalrevenueandnetincome2010-2012(USDMillion)101 AboutUs: PersistenceMarketResearchisaglobalmarketresearchfirmspecializing-syndicatedresearch,customresearch,andconsultingservices AtPersistenceMarketResearch(PMR),weareinthebusinessofacceleratingyourbusiness.Asafull- servicemarketresearchfirm,westandcommittedtobringingmoreaccuracyandspeedtoyourbusiness decisions.Fromready-to-purchasemarketresearchreportstocustomizedglobalresearchsolutions,our engagementmodelsarehighlyflexiblewithoutcompromisingonourdeep-seatedresearchvalues. Brieflystated,ourmissionistogiveyouaccesstoforecastsandtrendsanalysesthatputyouonthe pathto profitability. PMR’sServicesGoBeyondGleaningData 23 PersistenceMarketResearch

  24. BeautyDevicesMarket-GlobalStudyonClinicalTrialManagement System-AsiatoWitnessHighestGrowthby2019 MostenterprisesbelievethatITanddatabasesareenoughtomakeanaccuratedecision.Whilewedo notdisputethat,considerthis:Howlongdoesittaketomakeanaccurate decision?Westrivetodeliverbothevenwithdemandingdeadlines. andstrategicmillion-dollar ContactUs: AddieThomes 305Broadway 7thFloor,NewYorkCity, NY10007,UnitedStates, USA-CanadaTollFree:800-961-0353 Email:sales@persistencemarketresearch.com Web:http://www.persistencemarketresearch.com 24 PersistenceMarketResearch

More Related